Search Results

There are 39256 results for: content related to: Advances in the Prediction of Protein–Peptide Binding Affinities: Implications for Peptide-Based Drug Discovery

  1. You have free access to this content
    Predicting the Binding Affinity of Epitope-Peptides with HLA-A*0201 by Encoding Atom-Pair Non-covalent Interaction Information between Receptor and Ligands

    Chemical Biology & Drug Design

    Volume 75, Issue 6, June 2010, Pages: 597–606, Lu Hu, Zhenglin Ai, Ping Liu, Quan Xiong, Min Min, Chunhui Lan, Jun Wang, Lilin Fan and Dongfeng Chen

    Version of Record online : 4 MAY 2010, DOI: 10.1111/j.1747-0285.2010.00975.x

  2. You have free access to this content
    The Evolution of HLA-B*3501 Binding Affinity to Variable Immunodominant NP418-426 Peptides from 1918 to 2009 Pandemic Influenza A Virus: A Molecular Dynamics Simulation and Free Energy Calculation Study

    Chemical Biology & Drug Design

    Volume 79, Issue 6, June 2012, Pages: 1025–1032, Jingjing Guo, Xiaoting Wang, Huijun Sun, Huanxiang Liu, Yulin Shen and Xiaojun Yao

    Version of Record online : 19 MAR 2012, DOI: 10.1111/j.1747-0285.2012.01357.x

  3. Quantum Topological QSAR Models based on the MOLMAP Approach

    Chemical Biology & Drug Design

    Volume 72, Issue 6, December 2008, Pages: 551–563, Bahram Hemmateenejad, Ahmad R. Mehdipour and Paul L. A. Popelier

    Version of Record online : 19 NOV 2008, DOI: 10.1111/j.1747-0285.2008.00731.x

  4. Conformational mapping of the N-terminal segment of surfactant protein B in lipid using 13C-enhanced Fourier transform infrared spectroscopy

    The Journal of Peptide Research

    Volume 55, Issue 4, April 2000, Pages: 330–347, L.M. Gordon, K. Y. C. Lee, M.M. Lipp, J.A. Zasadzinski, F.J. Walther, M.A. Sherman and A.J. Waring

    Version of Record online : 28 FEB 2002, DOI: 10.1034/j.1399-3011.2000.00693.x

  5. You have free access to this content
    Tumor Necrosis Factor Alpha Converting Enzyme: An Encouraging Target for Various Inflammatory Disorders

    Chemical Biology & Drug Design

    Volume 75, Issue 5, May 2010, Pages: 415–443, Malkeet S. Bahia and Om Silakari

    Version of Record online : 12 MAR 2010, DOI: 10.1111/j.1747-0285.2010.00950.x

  6. You have free access to this content
    Synthetic Biotinylated Peptide Compound, BP21, Specifically Recognizes Lysophosphatidylcholine Micelles

    Chemical Biology & Drug Design

    Volume 80, Issue 3, September 2012, Pages: 417–425, Akira Sato, Junken Aoki and Keiichi Ebina

    Version of Record online : 3 JUL 2012, DOI: 10.1111/j.1747-0285.2012.01413.x

  7. Prediction of primary structure deamidation rates of asparaginyl and glutaminyl peptides through steric and catalytic effects

    The Journal of Peptide Research

    Volume 63, Issue 5, May 2004, Pages: 437–448, N.E. Robinson and A.B. Robinson

    Version of Record online : 10 MAY 2004, DOI: 10.1111/j.1399-3011.2004.00148.x

  8. Mechanistic-Based Descriptors for QSAR Study of Psychotropic Drug Toxicity

    Chemical Biology & Drug Design

    Volume 72, Issue 5, November 2008, Pages: 409–435, Mahnaz Esteki and Taghi Khayamian

    Version of Record online : 16 OCT 2008, DOI: 10.1111/j.1747-0285.2008.00718.x

  9. Medicine pipeline: Structure-Based Drug Design and the Discovery of Aliskiren (Tekturna®): Perseverance and Creativity to Overcome a R&D Pipeline Challenge

    Chemical Biology & Drug Design

    Volume 70, Issue 6, December 2007, Pages: 557–565, Nissim Claude Cohen

    Version of Record online : 12 NOV 2007, DOI: 10.1111/j.1747-0285.2007.00599.x

  10. ‘100 years of peptide synthesis’: ligation methods for peptide and protein synthesis with applications to β-peptide assemblies

    The Journal of Peptide Research

    Volume 65, Issue 2, February 2005, Pages: 229–260, T. Kimmerlin and D. Seebach

    Version of Record online : 10 FEB 2005, DOI: 10.1111/j.1399-3011.2005.00214.x

  11. You have free access to this content
    Synthesis, Biological Evaluation, Mechanism of Action and Quantitative Structure–Activity Relationship Studies of Chalcones as Antibacterial Agents

    Chemical Biology & Drug Design

    Volume 73, Issue 4, April 2009, Pages: 403–415, Ponnurengam Malliappan Sivakumar, Sobana Priya and Mukesh Doble

    Version of Record online : 6 MAR 2009, DOI: 10.1111/j.1747-0285.2009.00793.x

  12. You have free access to this content
    Structure and Activity of CPNGRC: A Modified CD13/APN Peptidic Homing Motif

    Chemical Biology & Drug Design

    Volume 75, Issue 6, June 2010, Pages: 551–562, Leigh A. Plesniak, Bridget Salzameda, Holly Hinderberger, Elizabeth Regan, James Kahn, Stephen A. Mills, Peter Teriete, Yong Yao, Patricia Jennings, Francesca Marassi and Joseph A. Adams

    Version of Record online : 30 MAR 2010, DOI: 10.1111/j.1747-0285.2010.00974.x

  13. DFT-based de novo QSAR of Phenoloxidase Inhibitors

    Chemical Biology & Drug Design

    Volume 71, Issue 5, May 2008, Pages: 483–493, Farhan Ahmad Pasha, Muhhammad Muddassar, Yakub Beg and Seung Joo Cho

    Version of Record online : 8 APR 2008, DOI: 10.1111/j.1747-0285.2008.00651.x

  14. Quantitative Structure–Activity Relationship and Classification Analysis of Diaryl Ureas Against Vascular Endothelial Growth Factor Receptor-2 Kinase Using Linear and Non-Linear Models

    Chemical Biology & Drug Design

    Volume 73, Issue 6, June 2009, Pages: 644–654, Min Sun, Junqing Chen, Hongtao Wei, Shuangqing Yin, Yan Yang and Min Ji

    Version of Record online : 17 APR 2009, DOI: 10.1111/j.1747-0285.2009.00814.x

  15. Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Aβ1–40 fibrillogenesis

    The Journal of Peptide Research

    Volume 60, Issue 1, July 2002, Pages: 37–55, D.J. Gordon, R. Tappe and S.C. Meredith

    Version of Record online : 25 JUN 2002, DOI: 10.1034/j.1399-3011.2002.11002.x

  16. The Future of Peptide-based Drugs

    Chemical Biology & Drug Design

    Volume 81, Issue 1, January 2013, Pages: 136–147, David J. Craik, David P. Fairlie, Spiros Liras and David Price

    Version of Record online : 17 DEC 2012, DOI: 10.1111/cbdd.12055

  17. In Silico Quantitative Structure–Toxicity Relationship Study of Aromatic Nitro Compounds

    Chemical Biology & Drug Design

    Volume 73, Issue 5, May 2009, Pages: 537–544, Farhan Ahmad Pasha, Mohammad Morshed Neaz, Seung Joo Cho, Mohiuddin Ansari, Sunil Kumar Mishra and Sharvan Tiwari

    Version of Record online : 23 MAR 2009, DOI: 10.1111/j.1747-0285.2009.00799.x

  18. You have free access to this content
    Simultaneously Optimized Support Vector Regression Combined With Genetic Algorithm for QSAR Analysis of KDR/VEGFR-2 Inhibitors

    Chemical Biology & Drug Design

    Volume 75, Issue 5, May 2010, Pages: 494–505, Min Sun, Junqing Chen, Jin Cai, Meng Cao, Shuangqing Yin and Min Ji

    Version of Record online : 12 MAR 2010, DOI: 10.1111/j.1747-0285.2010.00958.x

  19. You have free access to this content
    Vicinal Diamino Functionalities as Privileged Structural Elements in Biologically Active Compounds and Exploitation of their Synthetic Chemistry

    Chemical Biology & Drug Design

    Volume 67, Issue 2, February 2006, Pages: 101–114, S. R. S. Saibabu Kotti, Cody Timmons and Guigen Li

    Version of Record online : 14 FEB 2006, DOI: 10.1111/j.1747-0285.2006.00347.x

  20. Rationalizing Protein–Ligand Interactions for PTP1B Inhibitors Using Computational Methods

    Chemical Biology & Drug Design

    Volume 74, Issue 6, December 2009, Pages: 582–595, Subhash Ajmani, Sudheer Karanam and Sudhir A. Kulkarni

    Version of Record online : 12 OCT 2009, DOI: 10.1111/j.1747-0285.2009.00894.x